The caller alleged a variance between the inratio inr result and the laboratory inr result.Results are as follows: date: (b)(6) 2015 inratio inr: n/a laboratory inr: 3.1 (b)(6) 2015, 2.2, n/a.Therapeutic range: 2.5 - 3.5.The patient was reported to be anemic.There was no reported adverse patient sequela.There was no additional information provided.
|
Investigation/conclusion: the customer reported a discrepant low inratio inr result during testing.It is indicated that product is not returning for evaluation.Since the product associated with the complaint was not returned, a review of in-house testing data was performed.The retain strip testing results met both accuracy and repeatability criteria.The product performed as expected and no product deficiencies were observed.A review of the manufacturing records for the lot did not uncover any relevant non-conformances and the lot met release specification.The patient was reported to be anemic, however, the hematocrit is unknown at the time of the complaint.The prior month, the hematocrit was reported to be 35.7.Anemia with a hematocrit less than 30% was identified as a condition that may contribute to discrepant inr results.A root cause could not be determined from the information provided by the customer.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
|